IMS trades up after allocation

A Eu550m term loan from US pharmaceutical industry intelligence provider IMS Health traded up in the secondary market after being allocated to lenders on Wednesday, said market participants.

  • 18 Feb 2010

The euro tranche, priced alongside a $1.25bn dollar loan, was priced at a margin of 375bp with a 1.75% Euribor floor and issued at 99%. It had reached 100.325% on Thursday, said one fund manager, who welcomed the deal.

The deal backs the buyout of IMS by TPG Capital ...

Please take a trial or subscribe to access this content.

Contact Mark Goodes to discuss your access: mark.goodes@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

GlobalCapital European securitization league table

Rank Lead Manager/Arranger Share % by Volume
1 Societe Generale 41.30
2 Rabobank 35.35
3 Morgan Stanley 11.45
4 BNP Paribas 5.95
4 Credit Agricole 5.95

Bookrunners of Global Structured Finance

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 CITIC Securities 1,560.67 2 10.70%
2 SG Corporate & Investment Banking 1,445.74 4 9.92%
3 Wells Fargo Securities 1,187.61 3 8.15%
4 Rabobank 1,081.86 1 7.42%
5 Bank of America Merrill Lynch 831.08 4 5.70%